Cite

    Jacobse, J. et al. (2021). Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial. British journal of clinical pharmacology. 87 (8), pp. 3162-3176. [Online].